Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy, to the federal newborn screening list to enable early treatment, the Department of Health and Human Services said.
The decision updates the Recommended Uniform Screening Panel (RUSP), which guides state-level newborn screening programs, following a scientific review and public comment process.
Early detection of Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD) will allow children to receive FDA-approved therapies at the most effective time, helping slow disease progression and preserve quality of life, the HHS said.
DMD, a rare genetic disorder, causes muscle degeneration, while MLD affects the brain and nervous system, which leads to loss of motor and cognitive function and early death.
Most children with DMD or MLD are diagnosed at age four or five, when significant muscle loss or neurological decline has already occurred, the HHS said.
The agency said that screening at birth could reduce years-long diagnostic delays, repeated specialist visits, and the financial and emotional strain often associated with rare diseases.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli)
Manual for 6 Busssiness Class Flights- Best Streaming Gadget for Your Home Theater
- Parents who delay baby's first vaccines also likely to skip measles shots
- From a new flagship space telescope to lunar exploration, global cooperation – and competition – will make 2026 an exciting year for space
- Exploring the Mind boggling Universe of Connections: Individual Bits of knowledge
- Paraplegic engineer becomes the first wheelchair user to blast into space
- Peloton recalls more than 800,000 bikes after broken seat posts injure users
- 5 Great High-Mileage Electric Vehicles Of 2024
- Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
